BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 164 filers reported holding BLUEBIRD BIO INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $37 | -67.5% | 26,760 | -22.8% | 0.00% | -71.4% |
| Q2 2023 | $114 | -99.9% | 34,654 | +23.4% | 0.01% | +7.7% |
| Q2 2022 | $116,000 | -25.6% | 28,075 | -12.7% | 0.01% | -27.8% |
| Q1 2022 | $156,000 | -77.4% | 32,167 | +49.3% | 0.02% | -73.9% |
| Q2 2021 | $689,000 | +115.3% | 21,550 | +956.4% | 0.07% | +43.8% |
| Q2 2018 | $320,000 | +31.7% | 2,040 | +43.2% | 0.05% | +33.3% |
| Q1 2018 | $243,000 | -16.8% | 1,425 | -32.9% | 0.04% | -23.4% |
| Q3 2017 | $292,000 | – | 2,123 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 62,000 | $2,683,000 | 1.55% |
| ARMISTICE CAPITAL, LLC | 878,000 | $37,991,000 | 1.29% |
| Camber Capital Management LP | 800,000 | $34,616,000 | 1.22% |
| Casdin Capital, LLC | 915,000 | $39,592,000 | 1.17% |
| Tarsadia Capital, LLC | 80,744 | $3,494,000 | 0.72% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 7,900 | $342,000 | 0.54% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 535,573 | $23,174,000 | 0.53% |
| Bullseye Asset Management LLC | 32,845 | $1,421,000 | 0.53% |
| XTX MARKETS LLC | 5,728 | $248,000 | 0.51% |
| DAFNA Capital Management LLC | 30,273 | $1,310,000 | 0.39% |